Consolidated Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash & cash equivalents	$ 19,368	$ 91,643
Accounts receivable	86,710	25,400
Inventory	18,210	6,499
Deferred costs	7,889
Prepaid expenses	149,250	7,608
Total current assets	281,427	131,150
OTHER ASSETS
Deferred offering costs	64,236	64,236
Pre-production costs	148,000
Total other assets	212,236	64,236
Total Assets	493,663	195,386
CURRENT LIABILITIES
Accounts payable - related parties	249,839	255,250
Accounts payable	38,288	16,142
Deferred revenue	46,958
Accrued interest, convertible notes payable	106,503	28,964
Convertible notes payable (net of unamortized debt discounts of $143,545 and $124,563 and unamortized debt premium of $1,480,003 and $504,386 respectively)	3,939,153	1,355,823
Total current liabilities	4,380,741	1,656,179
Total Liabilities	4,380,741	1,656,179
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, par value $.01 per share; 10,000,000 shares authorized, 240,000 issued and outstanding	2,400	2,400
Common stock, par value $.0001 per share; shares 2,000,000,000 authorized; 33,384,036 and 16,712,819 issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	3,338	1,671
Additional paid-in capital	(135,231)	567,738
Accumulated (deficit)	(3,757,585)	(2,032,602)
Total stockholders' equity (deficit)	(3,887,078)	(1,460,793)
Total Liabilities and Stockholders' Equity (Deficit)	$ 493,663	$ 195,386

Pre-production costs.

No definition available.

Name:	ADGO_PreproductionCosts
Namespace Prefix:	ADGO_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).